Biokit USA
Werfen, a prominent leader in the field of specialized diagnostics, focuses on enhancing patient care through innovative solutions in areas such as hemostasis, acute care diagnostics, and transfusion medicine. With a commitment to quality and compliance, the company provides high-quality diagnostic systems and services to labs and hospitals across the globe.
With the recent acquisition of Omixon, Werfen expands its expertise in Next Generation Sequencing technologies for transplant diagnostics, further solidifying its mission of delivering reliable and accurate diagnostic results. Emphasizing the value of its workforce, Werfen recognizes that its employees play a crucial role in achieving the company's goals and maintaining their standards of excellence.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.

